Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Pulmonary Alveolar Proteinosis After Allogeneic Stem Cell Transplant in a Patient Undergoing Multiagent Chronic Graft‐Versus‐Host‐Disease Treatment Including Axatilimab. Local targets link to admitted publications; unresolved targets remain external evidence.
Pulmonary Alveolar Proteinosis
10.1038/s41572-019-0066-3 · 2019 · External reference
Pulmonary Alveolar Proteinosis After Allogeneic Hematopoietic Stem‐Cell Transplantation in Adults: A French Societe Francophone de Greffe de Moelle et Therapie Cellulaire Survey
10.1016/j.chest.2021.05.056 · 2021 · External reference
Sirolimus‐Induced Secondary Pulmonary Alveolar Proteinosis
10.1016/j.rmcr.2021.101566 · 2022 · External reference
Sirolimus‐Induced Pulmonary Alveolar Proteinosis in the Context of Hematopoietic Stem Cells Transplant Rejection: A Case Report
10.1016/j.transproceed.2021.12.006 · 2022 · External reference
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft‐Versus‐Host Disease: IV. The 2020 Highly Morbid Forms Report
10.1016/j.jtct.2021.06.001 · 2021 · External reference
Increasing Incidence of Chronic Graft‐Versus‐Host Disease in Allogeneic Transplantation: A Report From the Center for International Blood and Marrow Transplant Research
10.1016/j.bbmt.2014.10.021 · 2015 · External reference
FDA‐Approved Therapies for Chronic GVHD
10.1182/blood.2024026633 · 2025 · External reference
Updates in Chronic Graft‐Versus‐Host Disease Management
10.1002/ajh.27040 · 2023 · External reference
Extracorporeal Photopheresis as an Immunomodulatory Treatment Modality for Chronic GvHD and the Importance of Emerging Biomarkers
10.3389/fimmu.2023.1086006 · 2023 · External reference
Axatilimab in Recurrent or Refractory Chronic Graft‐Versus‐Host Disease
10.1056/nejmoa2401537 · 2024 · External reference
Pulmonary Alveolar Proteinosis: From Classification to Therapy
10.1183/20734735.0018-2020 · 2020 · External reference
National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft‐Versus‐Host Disease: I. The 2014 Diagnosis and Staging Working Group Report
10.1016/j.bbmt.2014.12.001 · 2015 · External reference
Pulmonary Alveolar Proteinosis: Progress in the First 44 Years
10.1164/rccm.2109105 · 2002 · External reference
Transbronchial Lung Biopsy (TBLB) in Diagnosing Pulmonary Alveolar Proteinosis (PAP): Forgotten Role in Australia?
10.1002/rcr2.129 · 2015 · External reference
Pulmonary Alveolar Proteinosis
10.1055/s-0032-1325160 · 2012 · External reference
Spontaneous Factor VIII Inhibitor Occurring in Association With Chronic Graft‐Versus‐Host Disease
10.1002/ajh.2830450309 · 1994 · External reference
Rituximab as a Treatment for Factor VIII Inhibitor in a Patient With Chronic GVHD
10.1038/bmt.2013.229 · 2014 · External reference
